222
Views
34
CrossRef citations to date
0
Altmetric
Original Research

Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer

, , , , , , , , & show all
Pages 3521-3531 | Published online: 24 Sep 2013

References

  • BhartiACDonatoNSinghSAggarwalBBCurcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosisBlood20031011053106212393461
  • JobinCBradhamCARussoMPCurcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activityJ Immunol19991633474348310477620
  • KunnumakkaraABDiagaradjanePGuhaSCurcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene productsClin Cancer Res2008142128213618381954
  • AnandPSundaramCJhuraniSKunnumakkaraABAggarwalBBCurcumin and cancer: an “old-age” disease with an “age-old” solutionCancer Lett200826713316418462866
  • DuvoixABlasiusRDelhalleSChemopreventive and therapeutic effects of curcuminCancer Lett200522318119015896452
  • MitchellTMCorrespondence re: Somasundaram et al. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancerCancer Res2002623868387512097302 Cancer Res2003635165516612941849
  • SomasundaramSEdmundNAMooreDTSmallGWShiYYOrlowskiRZDietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancerCancer Res2002623868387512097302
  • van’t LandBBlijlevensNMMarteijnJRole of curcumin and the inhibition of NF-kappaB in the onset of chemotherapy-induced mucosal barrier injuryLeukemia20041827628414671640
  • DuBJiangLXiaQZhongLSynergistic inhibitory effects of curcumin and 5-fluorouracil on the growth of the human colon cancer cell line HT-29Chemotherapy200652232816340194
  • PatelBBSenguptaRQaziSCurcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1RInt J Cancer200812226727317918158
  • ChenYRTanTHInhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcuminOncogene1998171731789674701
  • ArbiserJLKlauberNRohanRCurcumin is an in vivo inhibitor of angiogenesisMol Med1998437638310780880
  • LinYGKunnumakkaraABNairACurcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathwayClin Cancer Res2007133423343017545551
  • DoraiTCaoYCDoraiBButtyanRKatzAETherapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivoProstate20014729330311398177
  • KunnumakkaraABAnandPAggarwalBBCurcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteinsCancer Lett200826919922518479807
  • BhaumikSAnjumRRangarajNPardhasaradhiBVKharACurcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediatesFEBS Lett199945631131410456330
  • AggarwalSIchikawaHTakadaYSandurSKShishodiaSAggarwalBBCurcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activationMol Pharmacol20066919520616219905
  • MenonLGKuttanRKuttanGAnti-metastatic activity of curcumin and catechinCancer Lett199914115916510454257
  • BishtSFeldmannGSoniSPolymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapyJ Nanobiotechnology20075317439648
  • LaoCDRuffinMTIVNormolleDDose escalation of a curcuminoid formulationBMC Complement Altern Med200661016545122
  • BishtKWagnerKHBulmerACCurcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compoundsToxicology20102788810019903510
  • ShahaniKSwaminathanSKFreemanDBlumAMaLPanyamJInjectable sustained release microparticles of curcumin: a new concept for cancer chemopreventionCancer Res2010704443445220460537
  • ShutavaTGBalkundiSSVangalaPLayer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenolsACS Nano200931877188519534472
  • ShiehYAYangSJWeiMFShiehMJAptamer-based tumor-targeted drug delivery for photodynamic therapyACS Nano201041433144220166743
  • WangTHeNPreparation, characterization and applications of low-molecular-weight alginate-oligochitosan nanocapsulesNanoscale2010223023920644799
  • HeNWangTJiangLWangDHuYZhangLTherapy for cerebral ischemic injury with erythropoietin-containing nanoparticlesJ Nanosci Nanotechnol2010105320532321125890
  • WangXYangLChenZGShinDMApplication of nanotechnology in cancer therapy and imagingCA Cancer J Clin2008589711018227410
  • WeiXGongCGouMBiodegradable poly(epsilon-caprolactone)-poly(ethylene glycol) copolymers as drug delivery systemInt J Pharm200938111819664700
  • GouMWeiXMenKPCL/PEG copolymeric nanoparticles: potential nanoplatforms for anticancer agent deliveryCurr Drug Targets2011121131115021443476
  • ShiHSGaoXLiDA systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiationInt J Nanomedicine201272601261122679371
  • SafavyARaischKPMantenaSDesign and development of water-soluble curcumin conjugates as potential anticancer agentsJ Med Chem2007506284628817973470
  • GuoGFuSZhouLPreparation of curcumin loaded poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone) nanofibers and their in vitro antitumor activity against glioma 9L cellsNanoscale201133825383221847493
  • MenKGouMLGuoQFA novel drug and gene co-delivery system based on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) grafted polyethyleneimine micelleJ Nanosci Nanotechnol2010107958796421121283
  • GouMZhengXMenKSelf-assembled hydrophobic honokiol loaded MPEG-PCL diblock copolymer micellesPharm Res2009262164217319568695
  • ShiHSLiDZhangJSilencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in miceCancer Sci20101011447145320507318
  • Lopes de MenezesDEPilarskiLMAllenTMIn vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphomaCancer Res199858332033309699662
  • JemalASiegelRWardECancer statistics, 2008CA Cancer J Clin200858719618287387
  • SherTDyGKAdjeiAASmall cell lung cancerMayo Clin Proc20088335536718316005
  • DetterbeckFCBoffaDJTanoueLTThe new lung cancer staging systemChest200913626027119584208
  • YanagawaHBandoHTakishitaYDose-intensive chemotherapy with cisplatin, vincristine, doxorubicin and etoposide against lung cancer: a pilot studyAnticancer Res1995156136167539241
  • Di SantoRCostiRArticoMDesign, synthesis and biological evaluation of heteroaryl diketohexenoic and diketobutanoic acids as HIV-1 integrase inhibitors endowed with antiretroviral activityFarmaco20056040941715910813
  • AbouzidKAKhalilNAAhmedEMZaitoneSASynthesis and biological evaluation of new heteroaryl carboxylic acid derivatives as anti-inflammatory-analgesic agentsChem Pharm Bull (Tokyo)20136122222823370197
  • XuYKuBTieLCurcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREBBrain Res20061122566417022948
  • ShiMCaiQYaoLMaoYMingYOuyangGAntiproliferation and apoptosis induced by curcumin in human ovarian cancer cellsCell Biol Int20063022122616376585
  • SenGSMohantySHossainDMCurcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 cross-talk in favor of p53-p300 in breast cancerJ Biol Chem2011286422324224722013068